Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease.
about
Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's DiseasesNovel mitochondrial targets for neuroprotectionMulti-target drugs: the trend of drug research and developmentAcetyl L-carnitine protects motor neurons and Rohon-Beard sensory neurons against ketamine-induced neurotoxicity in zebrafish embryos.Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury.Lipoamide Acts as an Indirect Antioxidant by Simultaneously Stimulating Mitochondrial Biogenesis and Phase II Antioxidant Enzyme Systems in ARPE-19 Cells.Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila.Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review.Pharmacological effects and clinical applications of propionyl-L-carnitine.Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.Preconditioning as a potential strategy for the prevention of Parkinson's disease.Hypoxic preconditioning protects cardiomyocytes against hypoxia/reoxygenation injury through AMPK/eNOS/PGC-1α signaling pathway.α-Lipoic Acid Inhibits Expression of IL-8 by Suppressing Activation of MAPK, Jak/Stat, and NF-κB in H. pylori-Infected Gastric Epithelial AGS Cells.α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review.Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration.ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.Mitochondrial nutrients stimulate performance and mitochondrial biogenesis in exhaustively exercised rats.
P2860
Q26859141-A7181E35-E385-4985-82BB-C973A4344D01Q27023108-3AABF60C-E252-429A-8CDF-51F25561F9DBQ28480888-66AEF519-1BF9-451D-AAF2-F473725452EEQ33787815-800810AA-ACD0-4D7B-891B-06967A4A1B5DQ33965418-469D30E0-B97B-4E53-8ED9-85DD8B5CE9D4Q35648531-B57D2667-124D-4971-8682-44EB5BBE696EQ35860358-2E509D09-CA42-44C6-B289-0CB2DED5C9E2Q36202527-73CBAAAA-9FD9-41C8-B389-9B17DD11229DQ37466088-BA3EE2E5-521F-46E7-823E-869111C28F25Q37580731-0750740F-6774-43BE-B13B-E56C4B9D221FQ37815174-B6BF22B3-C11F-4026-812E-1247E5FEA026Q37869187-15A2F197-E4B7-485A-8823-E501B623861EQ38009051-3E256936-BE34-434C-B380-8A5AC36841F1Q38086474-D668F536-07A2-492E-AF78-2C25414DA838Q38201685-9FB4E0AB-D056-4625-96EA-2BBA6907E32FQ38924223-C9BDB051-FEE2-40E6-8D29-49F02ED2D943Q40884823-0C302C0E-2B5E-4E9E-B18D-9FF463007B01Q46252229-0C935DB3-C16C-4CAE-8B84-B47BFCED5749Q47446148-F8083D1D-2A27-45A3-B207-0E5E9F6A5412Q48152730-5F5D81AF-FA30-4FEF-BBF2-D1A18D7A2F12Q53252894-CE37EDA1-F67C-4016-919A-6B1CCC7AAB50
P2860
Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined R-alpha-lipoic acid a ...... model of Parkinson's disease.
@en
Combined R-alpha-lipoic acid a ...... model of Parkinson's disease.
@nl
type
label
Combined R-alpha-lipoic acid a ...... model of Parkinson's disease.
@en
Combined R-alpha-lipoic acid a ...... model of Parkinson's disease.
@nl
prefLabel
Combined R-alpha-lipoic acid a ...... model of Parkinson's disease.
@en
Combined R-alpha-lipoic acid a ...... model of Parkinson's disease.
@nl
P2093
P2860
P50
P1476
Combined R-alpha-lipoic acid a ...... r model of Parkinson's disease
@en
P2093
Jianghai Liu
Jiankang Liu
Weili Shen
Xuemin Wang
P2860
P304
P356
10.1111/J.1582-4934.2008.00390.X
P577
2010-01-01T00:00:00Z